Eker, N. Et Al. 2022. Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation. JOURNAL OF PEDIATRIC RESEARCH , vol.9, no.2 , 197-200.

Eker, N., Tas, B. T., Doğru, Ö., Senay, E., Tokuç, A. G., & Koç, A., (2022). Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation. JOURNAL OF PEDIATRIC RESEARCH , vol.9, no.2, 197-200.

Eker, NURŞAH Et Al. "Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation," JOURNAL OF PEDIATRIC RESEARCH , vol.9, no.2, 197-200, 2022

Eker, NURŞAH Et Al. "Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation." JOURNAL OF PEDIATRIC RESEARCH , vol.9, no.2, pp.197-200, 2022

Eker, N. Et Al. (2022) . "Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation." JOURNAL OF PEDIATRIC RESEARCH , vol.9, no.2, pp.197-200.

@article{article, author={NURŞAH EKER Et Al. }, title={Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation}, journal={JOURNAL OF PEDIATRIC RESEARCH}, year=2022, pages={197-200} }